The world is being quietly rearranged by people who write very long documents.


The title they went with Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microbial Nucleic Acids by Fluorescence In Situ Hybridization in Clinical Specimens Noisy translates that to

Infection diagnostic devices get a faster path to market in the US


US health regulators just made it easier to sell devices that detect infections using a specific genetic test. This means manufacturers of these diagnostic tools will face less paperwork and a faster approval process.
New medical devices often face a long, expensive approval process, especially if they are novel. This rule means a specific type of infection-detecting device can now get to market with fewer regulatory hurdles. This could speed up how quickly doctors can diagnose certain infections.
Watch for an increase in the number of new infection-detecting devices that receive US approval in the next two years.

If you insist
Read the original →